Cargando…

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients

OBJECTIVES: Development of direct acting antivirals (DAA) offers new benefits for patients with chronic hepatitis C. The combination of these drugs with antiretroviral treatment (cART) is a real challenge in HIV/HCV coinfected patients. The aim of this study was to describe potential drug-drug inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poizot-Martin, Isabelle, Naqvi, Alissa, Obry-Roguet, Véronique, Valantin, Marc-Antoine, Cuzin, Lise, Billaud, Eric, Cheret, Antoine, Rey, David, Jacomet, Christine, Duvivier, Claudine, Pugliese, Pascal, Pradat, Pierre, Cotte, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619009/ https://www.ncbi.nlm.nih.gov/pubmed/26488159 http://dx.doi.org/10.1371/journal.pone.0141164

Ejemplares similares

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study
por: Cotte, Laurent, et al.
Publicado: (2017)

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France
por: Rojas Rojas, Teresa, et al.
Publicado: (2022)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
por: Lions, C., et al.
Publicado: (2019)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014)

Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort
por: Billa, Oumar, et al.
Publicado: (2018)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients
por: Salmon, Dominique, et al.
Publicado: (2018)

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
por: Poizot‐Martin, I., et al.
Publicado: (2020)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
por: Shili-Masmoudi, Sarah, et al.
Publicado: (2019)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
por: Wang, Yu, et al.
Publicado: (2021)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016)

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
por: Allavena, Clotilde, et al.
Publicado: (2014)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score
por: Hentzien, Maxime, et al.
Publicado: (2018)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)

Therapeutic issues in HIV/HCV-coinfected patients
por: Sulkowski, M S, et al.
Publicado: (2007)

Virological Mechanisms in the Coinfection between HIV and HCV
por: Liberto, Maria Carla, et al.
Publicado: (2015)

Evidence for Implementation: HIV/HCV Coinfection and Pregnancy
por: Curtis, Megan Rose, et al.
Publicado: (2023)

Cellular Activation and Intracellular HCV Load in Peripheral Blood Monocytes Isolated from HCV Monoinfected and HIV-HCV Coinfected Patients
por: Dichamp, Isabelle, et al.
Publicado: (2014)

Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain
por: Domínguez-Rodríguez, Sara, et al.
Publicado: (2020)

Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients
por: Fuster, Daniel, et al.
Publicado: (2021)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

HCV-HIV Chronic Coinfection Prevalence in Amazon Region
por: Lobo, Marcio Nahum, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o5kkuchc3ibu5c2ub0h5p2a344